{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:40:20Z","timestamp":1792474820816,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.plefa.2026.102778","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:49:19Z","timestamp":1790981359000},"page":"102778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acetylsalicylic acid (ASA) affects arachidonic acid metabolites, dihydroxyeicosatrienoic acids and hydroxyeicosatetraenoic acids and suppresses Thromboxane B2 in human plasma and urine. A randomized single blinded trial evaluating the effects of ASA on polyunsaturated fatty acid metabolism within a period of 24 hours"],"prefix":"10.1016","volume":"211","author":[{"given":"Julia","family":"Menke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Zukunft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen J","family":"Schoettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Simon","family":"Centner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3163-571X","authenticated-orcid":false,"given":"Marc","family":"Revermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.plefa.2026.102778_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots - a concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102778_bib0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.plipres.2017.04.003","article-title":"Prostaglandin synthases: molecular characterization and involvement in prostaglandin biosynthesis","volume":"66","author":"Seo","year":"2017","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102778_bib0003","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.rmed.2018.01.002","article-title":"Aspirin exacerbated respiratory disease: current topics and trends","volume":"135","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.plefa.2026.102778_bib0004","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1542\/peds.62.5S.867","article-title":"Clinical pharmacokinetics of aspirin","volume":"62","author":"Levy","year":"1978","journal-title":"Pediatrics"},{"issue":"5548","key":"10.1016\/j.plefa.2026.102778_bib0005","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.plefa.2026.102778_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0165-6147(00)01472-3","article-title":"New role for epoxyeicosatrienoic acids as anti-inflammatory mediators","volume":"21","author":"Campbell","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"issue":"39","key":"10.1016\/j.plefa.2026.102778_bib0007","doi-asserted-by":"crossref","first-page":"36059","DOI":"10.1074\/jbc.R100030200","article-title":"Epoxygenase pathways of arachidonic acid metabolism","volume":"276","author":"Zeldin","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.plefa.2026.102778_bib0008","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/nu10111689","article-title":"Possible Role of CYP450 generated omega-3\/Omega-6 PUFA metabolites in the modulation of blood pressure and vascular function in obese children","volume":"10","author":"Bonafini","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.plefa.2026.102778_bib0009","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/HJH.0b013e32831aedfa","article-title":"Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats","volume":"27","author":"Revermann","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.plefa.2026.102778_bib0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cbi.2018.12.004","article-title":"Subterminal hydroxyeicosatetraenoic acids: crucial lipid mediators in normal physiology and disease states","volume":"299","author":"Shoieb","year":"2019","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.plefa.2026.102778_bib0011","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jchromb.2014.03.015","article-title":"Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product","volume":"964","author":"Porro","year":"2014","journal-title":"J. Chromatogr. B"},{"issue":"4","key":"10.1016\/j.plefa.2026.102778_bib0012","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plefa.2026.102778_bib0013","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jdermsci.2015.03.010","article-title":"Dihomo-g-linolenic acid prevents the development of atopic dermatitis through prostaglandin D1 production in NC\/Tnd mice","volume":"79","author":"Amagai","year":"2015","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.plefa.2026.102778_bib0014","doi-asserted-by":"crossref","first-page":"931","DOI":"10.17219\/acem\/31243","article-title":"PUFAs: structures, metabolism and functions","volume":"24","author":"Wiktorowska-Owczarek","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"issue":"68","key":"10.1016\/j.plefa.2026.102778_bib0015","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis."},{"issue":"22","key":"10.1016\/j.plefa.2026.102778_bib0016","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14275","article-title":"Maximal exercise and erythrocyte epoxy fatty acids: a Lipidomics study","volume":"7","author":"Gollasch","year":"2019","journal-title":"Physiol. Rep."},{"issue":"17","key":"10.1016\/j.plefa.2026.102778_bib0017","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1016\/S0021-9258(18)31383-8","article-title":"Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins","volume":"268","author":"Carroll","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.plefa.2026.102778_bib0018","article-title":"20-HETE: Its potential role in physiological and pathophysiological processes","volume":"242","author":"Hou","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.plefa.2026.102778_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.prostaglandins.2006.05.002","article-title":"20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma","volume":"82","author":"Fang","year":"2007","journal-title":"Prostaglandins other Lipid Mediat."},{"issue":"3","key":"10.1016\/j.plefa.2026.102778_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/187231210791698438","article-title":"L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice","volume":"4","author":"Imaizumi","year":"2010","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.plefa.2026.102778_bib0021","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0022-2275(20)41155-1","article-title":"Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL","volume":"35","author":"Folcik","year":"1994","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.plefa.2026.102778_bib0022","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/nu9080825","article-title":"The linoleic acid: dihomo-\u03b3-linolenic acid ratio (LA:DGLA)-an emerging biomarker of Zn status","volume":"9","author":"Knez","year":"2017","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.plefa.2026.102778_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137785","article-title":"Selective Production of 9R-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid from \u03b1-Linolenic Acid in Perilla Seed Oil Hydrolyzate by a Lipoxygenase from Nostoc Sp. SAG 25.82","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.plefa.2026.102778_bib0024","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","article-title":"Clinical Pharmacokinetics of the Salicylates","volume":"10","author":"Needs","year":"1985","journal-title":"Clin. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.plefa.2026.102778_bib0025","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.4049\/jimmunol.173.8.5196","volume":"173","author":"Giri","year":"2004","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.plefa.2026.102778_bib0026","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365518809085748","article-title":"Measurements of the in vivo synthesis of thromboxane and prostacyclin in humans","volume":"48","author":"Vesterqvist","year":"1988","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"4","key":"10.1016\/j.plefa.2026.102778_bib0027","first-page":"265","article-title":"Comparative study on the effects of acetylsalicylic acid, indomethacin and paracetamol on metabolites of arachidonic acid in plasma, serum and urine in man","volume":"3","author":"Sepp\u00e4l\u00e4","year":"1983","journal-title":"Int. J. Clin. Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.plefa.2026.102778_bib0028","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1194\/jlr.M094219","article-title":"Epoxyeicosatrienoic acid (EET)-stimulated angiogenesis is mediated by epoxy hydroxyeicosatrienoic acids (EHETs) formed from COX-2","volume":"60","author":"Rand","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plefa.2026.102778_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-014-0033-4","article-title":"12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition","volume":"11","author":"Maskrey","year":"2014","journal-title":"J. Inflamm."},{"issue":"12","key":"10.1016\/j.plefa.2026.102778_bib0030","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1096\/fj.201600530R","article-title":"Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1","volume":"30","author":"Rauzi","year":"2016","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.plefa.2026.102778_bib0031","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1681\/ASN.2011080842","article-title":"The circadian clock modulates renal sodium handling","volume":"23","author":"Nikolaeva","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1-2","key":"10.1016\/j.plefa.2026.102778_bib0032","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0009-2797(00)00197-6","article-title":"Epoxide hydrolases: biochemistry and molecular biology","volume":"129","author":"Fretland","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.plefa.2026.102778_bib0033","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3164\/jcbn.2008047","article-title":"Role of linoleic acid hydroperoxide preformed by cyclooxygenase-1 or -2 on the regulation of prostaglandin formation from arachidonic acid by the respective enzyme","volume":"43","author":"Fujimoto","year":"2008","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.plefa.2026.102778_bib0034","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0024-3205(74)90163-5","article-title":"Metabolism of prostaglandin A. 1. The kidney cortex as a major site of PGA2 degradation","volume":"14","author":"Attallah","year":"1974","journal-title":"Life Sci."},{"key":"10.1016\/j.plefa.2026.102778_bib0035","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1097\/01.ju.0000110421.71910.c0","article-title":"The circadian rhythm of urine production, and urinary vasopressin and prostaglandin E2 excretion in healthy children","volume":"171","author":"Kamperis","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.plefa.2026.102778_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0952-3278(90)90171-G","article-title":"Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2","volume":"39","author":"Katayama","year":"1990","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"6","key":"10.1016\/j.plefa.2026.102778_bib0037","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0090-6980(97)00185-8","article-title":"Occurrence of 13(S)-hydroxyoctadecadienoic acid in biological samples","volume":"54","author":"Spindler","year":"1997","journal-title":"Prostaglandins"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327826000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:20:32Z","timestamp":1792473632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327826000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S0952327826000566"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102778","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylsalicylic acid (ASA) affects arachidonic acid metabolites, dihydroxyeicosatrienoic acids and hydroxyeicosatetraenoic acids and suppresses Thromboxane B2 in human plasma and urine. A randomized single blinded trial evaluating the effects of ASA on polyunsaturated fatty acid metabolism within a period of 24 hours","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2026.102778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102778"}}